Evidence map›Paper›PMID 25301938›Full record

ArticleThe Journal of biological chemistry2014

Structures of human steroidogenic cytochrome P450 17A1 with substrates.

Elyse M Petrunak, Natasha M DeVore, Patrick R Porubsky, Emily E Scott

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 66 papers.

0numbers the graph read from it
0cells of the map it votes in
66citing papers in PubMed
11.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

66 citing papers in PubMed, 122 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Recombinant Technologies Facilitate Drug Metabolism, Pharmacokinetics, and General Biomedical Research.Drug metabolism and disposition: the biological fate of chemicals · 2023
    Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Four Decades of Cytochrome P450 2B Research: From Protein Adducts to Protein Structures and Beyond.Drug metabolism and disposition: the biological fate of chemicals · 2023
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

6 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Elyse M PetrunakFrom the Department of Medicinal Chemistry, University of Kansas, Lawrence, Kansas 66045 and.
Natasha M DeVoreFrom the Department of Medicinal Chemistry, University of Kansas, Lawrence, Kansas 66045 and.
Patrick R Porubskythe Specialized Chemistry Center, University of Kansas, Lawrence, Kansas 66047.
Emily E ScottFrom the Department of Medicinal Chemistry, University of Kansas, Lawrence, Kansas 66045 and eescott@ku.edu.
University of Kansas · US

Funding

X-ray Absorption Spectroscopy (XAS) pp.711-759P41GM103393 · NIGMS · STANFORD UNIVERSITY · PI HODGSON, KEITH O · 2012 to 2019
$30.6M
TRAFFICKING OF THE PLASMA MEMBRANE CA2+-ATPASE TO RAFTSP20RR017708 · NCRR · UNIVERSITY OF KANSAS LAWRENCE · PI HANZLIK, ROBERT P · 2002 to 2011
$20.1M
Structural Basis of Cytochrome P450 ActivityR01GM076343 · NIGMS · UNIVERSITY OF KANSAS LAWRENCE · PI SCOTT, EMILY E · 2006 to 2014
$2.9M
Protein Structure and FunctionP20GM103420 · NIGMS · UNIVERSITY OF KANSAS LAWRENCE · PI HANZLIK, ROBERT P · 2012 to 2012
$2.0M
Structure and Function of Cytochrome P450 17A1R01GM102505 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI AUBE, JEFFREY, SCOTT, EMILY E · 2012 to 2015
$1.2M
INDUCIBLE OVEREXPRESSION OF NEUROTROPHINSK01RR000129 · NCRR · STANFORD UNIVERSITY · PI TOLWANI, RAVI J · 1999 to 2003
$460k
NCRR NIH HHS RR00129NCRR NIH HHS RR01778NIGMS NIH HHS GM103393NIGMS NIH HHS GM103420NIGMS NIH HHS P20 GM103420NIGMS NIH HHS P41 GM103393NIGMS NIH HHS R01 GM076343
6 · The paper itself

Abstract

The human cytochrome P450 17A1 (CYP17A1) enzyme operates at a key juncture of human steroidogenesis, controlling the levels of mineralocorticoids influencing blood pressure, glucocorticoids involved in immune and stress responses, and androgens and estrogens involved in development and homeostasis of reproductive tissues. Understanding CYP17A1 multifunctional biochemistry is thus integral to treating prostate and breast cancer, subfertility, blood pressure, and other diseases. CYP17A1 structures with all four physiologically relevant steroid substrates suggest answers to four fundamental aspects of CYP17A1 function. First, all substrates bind in a similar overall orientation, rising ∼60° with respect to the heme. Second, both hydroxylase substrates pregnenolone and progesterone hydrogen bond to Asn(202) in orientations consistent with production of 17α-hydroxy major metabolites, but functional and structural evidence for an A105L mutation suggests that a minor conformation may yield the minor 16α-hydroxyprogesterone metabolite. Third, substrate specificity of the subsequent 17,20-lyase reaction may be explained by variation in substrate height above the heme. Although 17α-hydroxyprogesterone is only observed farther from the catalytic iron, 17α-hydroxypregnenolone is also observed closer to the heme. In conjunction with spectroscopic evidence, this suggests that only 17α-hydroxypregnenolone approaches and interacts with the proximal oxygen of the catalytic iron-peroxy intermediate, yielding efficient production of dehydroepiandrosterone as the key intermediate in human testosterone and estrogen synthesis. Fourth, differential positioning of 17α-hydroxypregnenolone offers a mechanism whereby allosteric binding of cytochrome b5 might selectively enhance the lyase reaction. In aggregate, these structures provide a structural basis for understanding multiple key reactions at the heart of human steroidogenesis.

Indexed as

Catalytic DomainProtein Structure, Secondary17-alpha-HydroxyprogesteroneAndrostenesAndrostenolsBinding SitesCrystallography, X-RayDehydroepiandrosteroneEstrogensHemeHumansHydrogen BondingKineticsModels, MolecularMolecular StructureMutation17-alpha-HydroxyprogesteroneabirateroneAndrostenesAndrostenolsCYP17A1 protein, humanDehydroepiandrosteroneEstrogensHemePregnenoloneProgesteroneSteroid 17-alpha-HydroxylaseSteroidsTestosteroneCytochromeCytochrome P450Prostate CancerProtein StructureSteroidSteroidogenesisX-ray Crystallography

Identifiers

PMID25301938
PMCPMC4239641
OpenAlexW2144999739

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.